logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Taizo Uchimoto

osaka medical & pharmaceutical university
H指数:15
被引数:580

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author's reply to 'Bayesian interpretation of febrile neutropenia risk and primary G-CSF prophylaxis during darolutamide triplet therapy'

作者回复：“达罗鲁胺三联疗法期间发热性中性粒细胞减少症风险和初级G-CSF预防的贝叶斯解释”

Japanese Journal of Clinical Oncology
IF2.2
2026-08-010
PRE
Uchimoto, Taizo; Hirosuna, Kensuke; Niigawa, Heima; Jo, Taisuke; Morinaka, Hirofumi; Fukuokaya, Wataru; Yoshizawa, Atsuhiko; Saruta, Masanobu; Morita, Tsuyoshi; Fujimoto, Saizo; Yamamoto, Yutaka; Sakamoto, Moritoshi; Nishimura, Kazuki; Maenosono, Ryoichi; Tsujino, Takuya; Nishio, Kyosuke; Yoshikawa, Yuki; Ichihashi, Atsushi; Urabe, Fumihiko; Mori, Keiichiro; Yanagisawa, Takafumi; Tsuzuki, Shunsuke; Takahara, Kiyoshi; Inamoto, Teruo; Fujita, Kazutoshi; Azuma, Haruhito; Kimura, Takahiro; Komura, Kazumasa
REAL-WORLD OUTCOMES OF IO-BASED FIRST-LINE THERAPY IN METASTATIC RENAL CELL CARCINOMA PATIENTS ON HEMODIALYSIS

IO-Based一线疗法在行血液透析的转移性肾细胞癌患者中的真实世界疗效

Journal of Urology
IF6.8
2026-05-010
PRE
Takahashi, Hidetsugu; Yanagisawa, Takafumi; Okamoto, Maria; Fukuokaya, Wataru; Urabe, Fumihiko; Mori, Keiichiro; Murakami, Masaya; Kawada, Tatsushi; Katayama, Satoshi; Yamanoi, Tomoaki; Bekku, Kensuke; Uchimoto, Taizo; Tsujino, Takuya; Nishimura, Kazuki; Maenosono, Ryoichi; Adachi, Takahiro; Hashimoto, Takeshi; Toyoda, Shingo; Nukaya, Takuhisa; Morinaka, Hirofumi; Tamura, Keita; Araki, Motoo; Ohno, Yoshio; Fujita, Kazutoshi; Takahara, Kiyoshi; Komura, Kazumasa; Inamoto, Teruo; Azuma, Haruhito; Kimura, Takahiro
The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line ARPI Therapy

影像学进展而无PSA进展在一线ARPI治疗的新发转移性激素敏感性前列腺癌患者中的预后意义

The Prostate
IF0
2026-03-150
OAAI
Takeshi Tsutsumi; Shogo Yamazaki; Takuya Matsuda; Takuya Tsujino; Taizo Uchimoto; Takafumi Yanagisawa; Keiichiro Mori; Wataru Fukuokaya; Fumihiko Urabe; Masanobu Saruta; Atsuhiko Yoshizawa; Shingo Toyoda; Saizo Fujimoto; Kyosuke Nishio; Moritoshi Sakamoto; Tatsuo Fukushima; Ko Nakamura; Kazuki Nishimura; Keita Nakamori; Tomohisa Matsunaga; Yuki Yoshikawa; Ryoichi Maenosono; Kiyoshi Takahara; Teruo Inamoto; Takahiro Kimura; Kazutoshi Fujita; Kazumasa Komura; Haruhito Azuma
Age-stratified clinical outcomes and adverse events in patients with metastatic castration-sensitive prostate cancer receiving triplet therapy with darolutamide, androgen deprivation therapy, and docetaxel

按年龄分层的转移性去势敏感前列腺癌患者接受达罗他胺、雄激素剥夺疗法和紫杉醇三联疗法后的临床结局与不良事件

Japanese Journal of Clinical Oncology
IF2.2
2026-02-011
PRE
Uchimoto, Taizo; Hirosuna, Kensuke; Niigawa, Heima; Jo, Taisuke; Morinaka, Hirofumi; Fukuokaya, Wataru; Yoshizawa, Atsuhiko; Saruta, Masanobu; Morita, Tsuyoshi; Fujimoto, Saizo; Yamamoto, Yutaka; Sakamoto, Moritoshi; Nishimura, Kazuki; Maenosono, Ryoichi; Tsujino, Takuya; Nishio, Kyosuke; Yoshikawa, Yuki; Ichihashi, Atsushi; Urabe, Fumihiko; Mori, Keiichiro; Yanagisawa, Takafumi; Tsuzuki, Shunsuke; Takahara, Kiyoshi; Inamoto, Teruo; Fujita, Kazutoshi; Azuma, Haruhito; Kimura, Takahiro; Komura, Kazumasa
Prognostic impact of lung metastasis in patients treated with androgen receptor signaling inhibitors for castration-sensitive prostate cancer: data from the ULTRA-Japan Consortium

去势敏感型前列腺癌患者接受雄激素受体信号抑制剂治疗后肺转移的预后影响: 来自超日本财团的数据

JAPANESE JOURNAL OF CLINICAL ONCOLOGY
IF2.2
2025-10-010
PRE
Uchimoto, Taizo; Hirosuna, Kensuke; Niigawa, Heima; Kakumae, Sho; Morinaka, Hirofumi; Fukuokaya, Wataru; Yoshizawa, Atsuhiko; Saruta, Masanobu; Fujimoto, Saizo; Morita, Tsuyoshi; Yamamoto, Yutaka; Sakamoto, Moritoshi; Nishimura, Kazuki; Maenosono, Ryoichi; Tsujino, Takuya; Nishio, Kyosuke; Yoshikawa, Yuki; Ichihashi, Atsushi; Yamamoto, Shutaro; Iwatani, Kosuke; Urabe, Fumihiko; Mori, Keiichiro; Yanagisawa, Takafumi; Tsuduki, Shunsuke; Takahara, Kiyoshi; Inamoto, Teruo; Fujita, Kazutoshi; Azuma, Haruhito; Kimura, Takahiro; Komura, Kazumasa
Deciphering RCC immunotherapy outcomes: insights from a Japanese multi-institutional study on the CANLPH score's impact

解读RCC免疫治疗效果：日本多机构研究关于CANLPH评分影响的见解

WORLD JOURNAL OF UROLOGY
IF2.9
2025-02-241
PRE
Fukushima, Tatsuo; Tsujino, Takuya; Sakamoto, Moritoshi; Takahara, Kiyoshi; Komura, Kazumasa; Yanagisawa, Takafumi; Mori, Keiichiro; Fukuokaya, Wataru; Urabe, Fumihiko; Adachi, Takahiro; Hirasawa, Yosuke; Saruta, Masanobu; Yoshizawa, Atsuhiko; Toyoda, Shingo; Kawada, Tatsushi; Katayama, Satoshi; Iwatsuki, Kengo; Nakamura, Ko; Nishio, Kyosuke; Nishimura, Kazuki; Nakamori, Keita; Matsunaga, Tomohisa; Maenosono, Ryoichi; Uchimoto, Taizo; Takai, Tomoaki; Hashimoto, Takeshi; Inamoto, Teruo; Fujita, Kazutoshi; Araki, Motoo; Ohno, Yoshio; Shiroki, Ryoichi; Azuma, Haruhito
C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma
TARGETED ONCOLOGY
IF4
2024-05-285
PRE
Uchimoto, Taizo; Matsuda, Takuya; Komura, Kazumasa; Fukuokaya, Wataru; Adachi, Takahiro; Hirasawa, Yosuke; Hashimoto, Takeshi; Yoshizawa, Atsuhiko; Saruta, Masanobu; Hashimoto, Mamoru; Higashio, Takuya; Tsuchida, Shuya; Nishimura, Kazuki; Tsujino, Takuya; Nakamura, Ko; Fukushima, Tatsuo; Nishio, Kyosuke; Yamamoto, Shutaro; Iwatani, Kosuke; Urabe, Fumihiko; Mori, Keiichiro; Yanagisawa, Takafumi; Tsuduki, Shunsuke; Takahara, Kiyoshi; Inamoto, Teruo; Miki, Jun; Fujita, Kazutoshi; Kimura, Takahiro; Ohno, Yoshio; Shiroki, Ryoichi; Uemura, Hirotsugu; Azuma, Haruhito
Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors
TARGETED ONCOLOGY
IF4
2024-03-285
PRE
Uchimoto, Taizo; Tsuchida, Shuya; Komura, Kazumasa; Fukuokaya, Wataru; Adachi, Takahiro; Hirasawa, Yosuke; Hashimoto, Takeshi; Yoshizawa, Atsuhiko; Saruta, Masanobu; Hashimoto, Mamoru; Higashio, Takuya; Matsuda, Takuya; Nishimura, Kazuki; Tsujino, Takuya; Nakamura, Ko; Fukushima, Tatsuo; Nishio, Kyosuke; Yamamoto, Shutaro; Iwatani, Kosuke; Urabe, Fumihiko; Mori, Keiichiro; Yanagisawa, Takafumi; Tsuduki, Shunsuke; Takahara, Kiyoshi; Inamoto, Teruo; Miki, Jun; Fujita, Kazutoshi; Kimura, Takahiro; Ohno, Yoshio; Shiroki, Ryoichi; Uemura, Hirotsugu; Azuma, Haruhito
Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma

pembrolizumab治疗铂难治性尿路上皮癌后的重新挑战化疗

BJU INTERNATIONAL
IF4.4
2022-09-269
PRE
Uchimoto, Taizo; Fukushima, Tatsuo; Komura, Kazumasa; Fukuokaya, Wataru; Adachi, Takahiro; Hashimoto, Takeshi; Yoshizawa, Atsuhiko; Nakamura, Ko; Yano, Yusuke; Nishimura, Kazuki; Nishio, Kyosuke; Nakamori, Keita; Iwatani, Kosuke; Yamamoto, Shutaro; Urabe, Fumihiko; Mori, Keiichiro; Yanagisawa, Takafumi; Tsuduki, Shunsuke; Takahara, Kiyoshi; Inamoto, Teruo; Miki, Jun; Kimura, Takahiro; Ohno, Yoshio; Shiroki, Ryoichi; Egawa, Shin; Azuma, Haruhito
Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer
JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2022-01-1713
OAAI
Nishimura, Kazuki; Nishio, Kyosuke; Hirosuna, Kensuke; Komura, Kazumasa; Hayashi, Takuo; Fukuokaya, Wataru; Ura, Ayako; Uchimoto, Taizo; Nakamura, Ko; Fukushima, Tatsuo; Yano, Yusuke; Takahashi, Nobushige; Nakamori, Keita; Kinoshita, Shoko; Matsunaga, Tomohisa; Tsutsumi, Takeshi; Tsujino, Takuya; Taniguchi, Kohei; Tanaka, Tomohito; Uehara, Hirofumi; Takahara, Kiyoshi; Inamoto, Teruo; Hirose, Yoshinobu; Kimura, Takahiro; Egawa, Shin; Azuma, Haruhito
Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents
ONCOGENE
IF7.3
2021-09-2023
OAAI
Komura, Kazumasa; Inamoto, Teruo; Tsujino, Takuya; Matsui, Yusuke; Konuma, Tsuyoshi; Nishimura, Kazuki; Uchimoto, Taizo; Tsutsumi, Takeshi; Matsunaga, Tomohisa; Maenosono, Ryoichi; Yoshikawa, Yuki; Taniguchi, Kohei; Tanaka, Tomohito; Uehara, Hirofumi; Hirata, Koichi; Hirano, Hajime; Nomi, Hayahito; Hirose, Yoshinobu; Ono, Fumihito; Azuma, Haruhito
Risk stratification for the prediction of overall survival could assist treatment decision-making at diagnosis of castration-resistant prostate cancer: a multicentre collaborative study in Japan
BJU INTERNATIONAL
IF4.4
2020-08-104
PREAI
Uchimoto, Taizo; Komura, Kazumasa; Fukuokaya, Wataru; Kimura, Takahiro; Takahashi, Kazuhiro; Fujiwara, Yuya; Matsunaga, Tomohisa; Tsutsumi, Takeshi; Tsujino, Takuya; Maenosono, Ryoichi; Yoshikawa, Yuki; Taniguchi, Kohei; Tanaka, Tomohito; Uehara, Hirofumi; Ibuki, Naokazu; Hirano, Hajime; Nomi, Hayahito; Takahara, Kiyoshi; Inamoto, Teruo; Egawa, Shin; Azuma, Haruhito
Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort
JOURNAL OF CLINICAL MEDICINE
IF2.9
2019-08-1915
OAAI
Komura, Kazumasa; Fujiwara, Yuya; Uchimoto, Taizo; Saito, Kenkichi; Tanda, Naoki; Matsunaga, Tomohisa; Ichihashi, Atsushi; Tsutsumi, Takeshi; Tsujino, Takuya; Yoshikawa, Yuki; Nishimoto, Yudai; Takai, Tomoaki; Minami, Koichiro; Taniguchi, Kohei; Tanaka, Tomohito; Uehara, Hirofumi; Hirano, Hajime; Nomi, Hayahito; Ibuki, Naokazu; Takahara, Kiyoshi; Inamoto, Teruo; Azuma, Haruhito
Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy
ANNALS OF SURGICAL ONCOLOGY
IF3.5
2017-06-2227
PREAI
Tsujino, Takuya; Komura, Kazumasa; Matsunaga, Tomohisa; Yoshikawa, Yuki; Takai, Tomoaki; Uchimoto, Taizo; Saito, Kenkichi; Tanda, Naoki; Oide, Rintaro; Minami, Koichiro; Uehara, Hirofumi; Jeong, Seong Ho; Taniguchi, Kohei; Hirano, Hajime; Nomi, Hayahito; Ibuki, Naokazu; Takahara, Kiyoshi; Inamoto, Teruo; Azuma, Haruhito
Incidence of urethral stricture after bipolar transurethral resection of the prostate using TURis: results from a randomised trial

使用TURis进行双极经尿道前列腺切除术后尿道狭窄的发生率: 一项随机试验的结果

BJU INTERNATIONAL
IF4.4
2014-10-2452
PREAI
Komura, Kazumasa; Inamoto, Teruo; Takai, Tomoaki; Uchimoto, Taizo; Saito, Kenkichi; Tanda, Naoki; Minami, Koichiro; Oide, Rintaro; Uehara, Hirofumi; Takahara, Kiyoshi; Hirano, Hajime; Nomi, Hayahito; Kiyama, Satoshi; Watsuji, Toshikazu; Azuma, Haruhito

研究方向

暂未获取到该数据
K
Kiyoshi Takahara
H 指数:23论文数:217被引数:1,883
T
Teruo Inamoto
H 指数:29论文数:268被引数:3,113
H
Haruhito Azuma
H 指数:48论文数:462被引数:7,887
K
Kazumasa Komura
H 指数:25论文数:254被引数:2,353
H
Hajime Hirano
H 指数:17论文数:88被引数:838
T
Takuya Tsujino
H 指数:28论文数:164被引数:2,824
T
Tomoaki Takai
H 指数:21论文数:76被引数:1,616
H
Hayahito Nomi
H 指数:17论文数:111被引数:1,426
K
Kyosuke Nishio
H 指数:11论文数:87被引数:400
K
Kazuki Nishimura
H 指数:15论文数:102被引数:690